文献速递肿瘤 PET/CT核素与放射性配体治疗

乳腺癌患者的FAP靶向SPECT/CT与PET/CT显像

FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients.
PubMed 文献 · Clin Nucl Med · 2025-01-09

本综述聚焦乳腺癌中癌相关成纤维细胞高表达成纤维细胞激活蛋白(FAP)这一靶点,介绍FAP特异性放射性示踪剂联合PET/CT与SPECT/CT在乳腺癌早期检测、分期、治疗反应监测及治疗干预中的潜在价值,并探讨蛋白状态评估的先进技术、早期靶向治疗开发及其他新兴应用。

要点

  • 乳腺癌中癌相关成纤维细胞高表达成纤维细胞激活蛋白(FAP),是重要靶点。
  • FAP特异性放射性示踪剂联合PET/CT和SPECT/CT在乳腺癌早期检测、分期、治疗反应监测及治疗干预方面有显著潜力。
  • FAP靶向显像有望显著提升个体化肿瘤诊疗,改善乳腺癌管理和患者总体结局。

核心结论

  • FAP靶向分子显像有望显著提升个体化肿瘤诊疗,从而改善乳腺癌管理和患者总体结局。

研究设计与样本

  • 本文为综述,围绕FAP靶向分子显像,探讨蛋白状态评估的先进技术、早期靶向治疗的开发及其他新兴应用。

主要发现

  • 乳腺癌中癌相关成纤维细胞高度普遍并表达成纤维细胞激活蛋白(FAP),被视为关键靶点。
  • FAP特异性放射性示踪剂与PET/CT和SPECT/CT联合使用,在改善乳腺癌早期检测、分期、治疗反应监测及治疗干预方面具有显著潜力。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Breast cancer presents a significant global health challenge, necessitating continued innovation in diagnostic and therapeutic approaches. Recent advances have led to the identification of cancer-associated fibroblasts, which are highly prevalent in breast cancers and express fibroblast activation proteins (FAPs), as critical targets. FAP-specific radiotracers, when used with PET/CT and SPECT/CT, have significant potential for improving early breast cancer detection, staging, treatment response monitoring, and therapeutic intervention. This review provides insight into FAP-targeted molecular imaging, exploring advanced techniques for protein status assessment, development of early-phase targeted therapies, and other emerging applications. The advent of FAP-targeted imaging stands to significantly enhance personalized oncologic care, leading to improved breast cancer management and overall patient outcomes.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. McGale J, Khurana S, Howell H, et al. FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients. Clin Nucl Med. 2025. PMID: 39780367. doi:10.1097/RLU.0000000000005617

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。